濮阳东方看妇科病价格公开(濮阳东方医院男科割包皮值得选择) (今日更新中)

WASHINGTON, Jan. 20 (Xinhua) -- Visiting Chinese President Hu Jintao on Thursday called upon the U.S. Congress to continue helping the two countries boost their relations.Pursuing a healthy and steady development of China-U.S. ties is China's established policy and strategic choice, Hu stressed in talks here with Speaker John Boehner of the House and Majority leader Harry Reid of the Senate.It has also been the consensus of the U.S. administrations, whether Republican or Democratic, since the two countries established formal diplomatic relations 32 years ago, he added.Chinese President Hu Jintao (2nd L front) meets with U.S. Senate Majority Leader Harry Reid (2nd R front) on Capitol Hill in Washington, the United States, Jan. 20, 2011Thanks to the two nations' concerted efforts, the China-U.S. relationship has been moving forward steadily, Hu said, citing the two countries' increasing cooperation and coordination on trade, terrorism, climate change, Korean Peninsula denuclearization and other bilateral, regional and global issues.A sound relationship between Beijing and Washington not only serves the fundamental interests of both peoples, but greatly contributes to the peace, stability and prosperity of the Asia-Pacific region and beyond, the Chinese president said.With China and the United States differing in culture, social system and development level, it is normal for the two sides to have differences on some issues, he said.But what matters most is the common interests of the two countries, he stressed, saying that Beijing's position is that the two sides should seek common ground while reserving differences, so as to learn from each other and pursue common prosperity on the basis of mutual respect and equality.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

TOKYO, March 20 (Xinhua) -- Traces of radioactive iodine had been detected in Tokyo and the surrounding Kanto region, according to the results of an investigation of radioactivity in precipitation and dust conducted by the government, local media reported on Sunday.Radioactive iodine was found in Tokyo, Saitama, Chiba, Yamanashi, Tochigi and Gunma prefectures, the Kyodo News said, citing the Ministry of Education, Culture, Sports, Science and Technology. The ministry added that the levels detected in the investigation alone would not affect human health.An employee of Yamagata city office holds a Geiger counter to detect radiation when evacuees from the vicinity of Fukushima nuclear plant wish to be screened upon their arrival at an evacuation centre set in a gymnasium in Yamagata, northern Japan March 19, 2011, eight days after Japan's devastating earthquake and tsunami.The investigation was carried out following the nuclear crisis at the Fukushima Daiichi nuclear power plant, the government said Sunday.The ministry said that a separate research has already shown that radioactive materials in the air and tap water in Tokyo and the five prefectures pose no threat to human health, according to Kyodo News report.

VIENNA, March 18 (Xinhua) -- The 26th Annual Congress of the European Association of Urology (2011 EAU congress) kicked off on Friday at the Vienna Austria Center in the Austrian capital Vienna.About 14,000 doctors, experts, scholars and representatives of pharmaceutical enterprises in the field of urology from more than 80 countries took part in the event, which will last till Tuesday.The EAU congress is Europe's largest fair in the field of urology. This is the third time for Vienna to host the event.The EAU congress aims to review technical innovation and technological progress in the field of urology and related subspecialties, discuss new theories, new technologies and new diagnostic methods of urological clinical trials, optimize the risk management of urological disease, and enhance doctors' practical knowledge and skills by educational activities.It also provides an important platform for related pharmaceutical, medical equipments and medical consumables manufacturers to present their latest products and technologies, and creates the opportunity of face-to-face communication between suppliers and consumers.The highlights of this year's EAU congress include the discussion of state-of-the-art kidney imaging and the application of ultrasound, computerized tomography (CT-scan) and magnetic resonance imaging (MRI).Participants are also expected to give a timely overview on the role of imaging, focal therapy and kidney biopsy in the management and follow-up of small renal masses, as well as the use of imaging in the management of urinary incontinence and other pelvic urinary pathologies.Congress organizers said that more than 200 presentations and seminars are scheduled during the five-day meeting, with an estimated 400 speakers unveiling their latest findings.

SAN FRANCISCO, April 18 (Xinhua) -- Apple Inc. has sued Samsung Electronics Co. over patent infringement in a latest suit, U.S. media reported Monday.The suit, filed last Friday in U.S. District Court in Northern California, alleged that Samsung's smartphones, such as "Glaxy S 4G" and "Nexus S," and the Galaxy line of tablet computers violated Apple's patent and trademark, according to All Things Digital, a technology and startup company news site."It's no coincidence that Samsung's latest products look a lot like the iPhone and iPad, from the shape of the hardware to the user interface and even the packaging," the report quoted an Apple representative as saying.Intellectual property suits can be often seen among mobile computing rivals, including suits between Microsoft and Motorola, a suit by Oracle against Google, and Apple's patent dispute with Nokia and HTC.Although Samsung supplies chips for a number of Apple products, Apple CEO Steve Jobs once openly mocked Samsung and other tablet makers as "copycats" during the iPad2 launch. Last month, Apple is reportedly partnering with China's Taiwan Semiconductor Manufacturing Co. to make iPad chips.

来源：资阳报